TY - JOUR
T1 - A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the nationwide inpatient sample
AU - Ejaz, Aslam
AU - Sachs, Teviah
AU - He, Jin
AU - Spolverato, Gaya
AU - Hirose, Kenzo
AU - Ahuja, Nita
AU - Wolfgang, Christopher L.
AU - Makary, Martin A.
AU - Weiss, Matthew
AU - Pawlik, Timothy M.
PY - 2014/9
Y1 - 2014/9
N2 - Background The use of minimally invasive surgery (MIS) techniques for pancreatic and liver operations remains ill defined. We sought to compare inpatient outcomes among patients undergoing open versus MIS pancreas and liver operations using a nationally representative cohort. Methods We queried the Nationwide Inpatient Sample database for all major pancreatic and hepatic resections performed between 2000 and 2011. Appropriate International Classification of Diseases, 9th Revision (ICD-9) coding modifiers for laparoscopy and robotic assist were used to categorize procedures as MIS. Demographics, comorbidities, and inpatient outcomes were compared between the open and MIS groups. Results A total of 65,033 resections were identified (pancreas, n = 36,195 [55.7%]; liver, n = 28,035 [43.1%]; combined pancreas and liver, n = 803 [1.2%]). The overwhelming majority of operations were performed open (n = 62,192, 95.6%), whereas 4.4% (n = 2,841) were MIS. The overall use of MIS increased from 2.3% in 2000 to 7.5% in 2011. Compared with patients undergoing an open operation, MIS patients were older and had a greater incidence of multiple comorbid conditions. After operation, the incidence of complications for MIS (pancreas, 35.4%; liver, 29.5%) was lower than for open (pancreas, 41.6%; liver, 33%) procedures (all P <.05) resulting in a shorter median length of stay (8 vs 7 days; P =.001) as well as a lower in-hospital mortality (5.1% vs 2.8%; P =.001). Conclusion During the last decade, the number of MIS pancreatic and hepatic operations has increased, with nearly 1 in 13 HPB cases now being performed via an MIS approach. Despite MIS patients tending to have more preoperative medical comorbidities, postoperative morbidity, mortality, and duration of stay compared favorably with open surgery.
AB - Background The use of minimally invasive surgery (MIS) techniques for pancreatic and liver operations remains ill defined. We sought to compare inpatient outcomes among patients undergoing open versus MIS pancreas and liver operations using a nationally representative cohort. Methods We queried the Nationwide Inpatient Sample database for all major pancreatic and hepatic resections performed between 2000 and 2011. Appropriate International Classification of Diseases, 9th Revision (ICD-9) coding modifiers for laparoscopy and robotic assist were used to categorize procedures as MIS. Demographics, comorbidities, and inpatient outcomes were compared between the open and MIS groups. Results A total of 65,033 resections were identified (pancreas, n = 36,195 [55.7%]; liver, n = 28,035 [43.1%]; combined pancreas and liver, n = 803 [1.2%]). The overwhelming majority of operations were performed open (n = 62,192, 95.6%), whereas 4.4% (n = 2,841) were MIS. The overall use of MIS increased from 2.3% in 2000 to 7.5% in 2011. Compared with patients undergoing an open operation, MIS patients were older and had a greater incidence of multiple comorbid conditions. After operation, the incidence of complications for MIS (pancreas, 35.4%; liver, 29.5%) was lower than for open (pancreas, 41.6%; liver, 33%) procedures (all P <.05) resulting in a shorter median length of stay (8 vs 7 days; P =.001) as well as a lower in-hospital mortality (5.1% vs 2.8%; P =.001). Conclusion During the last decade, the number of MIS pancreatic and hepatic operations has increased, with nearly 1 in 13 HPB cases now being performed via an MIS approach. Despite MIS patients tending to have more preoperative medical comorbidities, postoperative morbidity, mortality, and duration of stay compared favorably with open surgery.
UR - http://www.scopus.com/inward/record.url?scp=84907598964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907598964&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2014.03.046
DO - 10.1016/j.surg.2014.03.046
M3 - Article
C2 - 25017135
AN - SCOPUS:84907598964
SN - 0039-6060
VL - 156
SP - 538
EP - 547
JO - Surgery (United States)
JF - Surgery (United States)
IS - 3
ER -